Idiopathic Pulmonary Fibrosis and Lung Transplantation: When it is Feasible
Despite the availability of antifibrotic therapies, many patients with idiopathic pulmonary fibrosis (IPF) will progress to advanced disease and require lung transplantation. International guidelines for transplant referral and listing of patients with interstitial lung disease are not specific to t...
Main Authors: | Elisabetta Balestro, Elisabetta Cocconcelli, Mariaenrica Tinè, Davide Biondini, Eleonora Faccioli, Marina Saetta, Federico Rea |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1010-660X/55/10/702 |
Similar Items
-
Clinical characteristics, comorbidities, and outcomes in patients with idiopathic pulmonary fibrosis
by: Esam H Alhamad, et al.
Published: (2020-01-01) -
Comorbidities and Complications in Idiopathic Pulmonary Fibrosis
by: Esteban Cano-Jiménez, et al.
Published: (2018-08-01) -
Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis
by: Keisuke Anan, et al.
Published: (2022-10-01) -
Exacerbation of idiopathic pulmonary fibrosis
by: S. N. Avdeev, et al.
Published: (2020-03-01) -
Underlying and immediate causes of death in patients with idiopathic pulmonary fibrosis
by: Miia Kärkkäinen, et al.
Published: (2018-05-01)